2022-11-24 14:47:50

Manitex International's Return On Capital Employed Overview - Manitex International (NASDAQ:MNTX)

Logo Benzinga
Benzinga
By Benzinga Insights

Benzinga Pro data, Manitex International MNTX reported Q3 sales of $65.04 million. Earnings fell to a loss of $3.08 million, resulting in a 46.65% decrease from last quarter. Manitex International collected $69.58 million in revenue during Q2, but reported earnings showed a $2.10 million loss.

What Is ROCE?

Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q3, Manitex International posted an ROCE of -0.05%.

Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future.

ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows Manitex International is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.

Continue read on benzinga.com

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-08 14:03:11
Pulled from Benzinga Pro data, IDEXX Laboratories IDXX posted Q3 earnings of $180.94 million, an increase from Q2 of 37.1%. Sales dropped to $841.66 million,...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-18 14:48:03
Pulled from Benzinga Pro data, Maxar Technologies MAXR posted Q3 earnings of $85.00 million, an increase from Q2 of 72.22%. Sales dropped to $436.00 million,...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-10-31 14:07:28
According to Benzinga Pro, during Q3, Axis Capital Holdings AXS earned $257.64 million, a 251.15% increase from the preceding quarter. Axis Capital Holdings...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-18 14:50:27
According to Benzinga Pro, during Q3, Idacorp IDA earned $106.63 million, a 65.09% increase from the preceding quarter. Idacorp also posted a total of...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-02 14:19:10
According to Benzinga Pro data, during Q3, PTC Therapeutics PTCT posted sales of $217.13 million. Earnings were up 28.12%, but PTC Therapeutics still...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-18 14:49:55
According to data from Benzinga Pro, during Q3, Athenex 's ATNX reported sales totaled $33.53 million. Despite a 38.62% increase in earnings, the company...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-10 13:52:58
According to Benzinga Pro data, during Q3, Zeta Global Holdings ZETA posted sales of $152.25 million. Earnings were up 19.26%, but Zeta Global Holdings still...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-07 14:08:34
According to Benzinga Pro, during Q3, MPLX MPLX earned $1.44 billion, a 62.56% increase from the preceding quarter. MPLX also posted a total of $3.40 billion...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-07 14:05:28
According to Benzinga Pro, during Q3, Civitas Resources CIVI earned $405.75 million, a 13.45% increase from the preceding quarter. Civitas Resources's sales...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-22 14:48:56
Benzinga Pro data, Diversey Holdings DSEY reported Q3 sales of $689.00 million. Earnings fell to a loss of $36.50 million, resulting in a 6.73% decrease from...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-21 14:49:12
According to data from Benzinga Pro, during Q3, Alphatec Holdings 's ATEC reported sales totaled $89.84 million. Despite a 0.86% increase in earnings, the...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-09 14:56:10
According to Benzinga Pro, during Q3, NMI Holdings NMIH earned $76.84 million, a 1.85% increase from the preceding quarter. NMI Holdings's sales decreased to...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-23 14:49:28
Karuna Therapeutics KRTX brought in sales totaling $81 thousand during Q3 according to data provided by Benzinga Pro. However, earnings decreased 18.51%,...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-18 14:48:44
Pulled from Benzinga Pro data, CSW Industrials CSWI posted Q2 earnings of $24.32 million, an increase from Q1 of 17.96%. Sales dropped to $191.19 million, a...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-09 14:55:27
According to data from Benzinga Pro, during Q3, MicroStrategy 's MSTR reported sales totaled $125.40 million. Despite a 97.45% increase in earnings, the...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-07 14:07:11
According to Benzinga Pro, during Q3, Eaton ETN earned $608.00 million, a 1.16% increase from the preceding quarter. Eaton also posted a total of $5.31...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-10-31 14:07:15
According to data from Benzinga Pro, during Q3, Impinj 's PI reported sales totaled $68.27 million. Despite a 80.92% increase in earnings, the company posted...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-22 14:50:22
Regenxbio RGNX brought in sales totaling $26.51 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 10.71%, resulting...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-21 14:49:22
Benzinga Pro data, CytoSorbents CTSO reported Q3 sales of $8.11 million. Earnings fell to a loss of $12.20 million, resulting in a 12.15% decrease from last...

Logo Benzinga
Business / FinanceBy Benzinga Insights2022-11-23 14:47:53
According to Benzinga Pro data, during Q3, Intra-Cellular Therapies ITCI posted sales of $71.87 million. Earnings were up 38.21%, but Intra-Cellular...